Eikon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that CEO and Board Chair, Roger M. Perlmutter, M.D., Ph.D., will provide a business update highlighting pipeline and clinical development progress in a presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 9:00 AM Pacific Standard Time.
Additional information about Eikon Therapeutics can be found on the company's website at: www.EikonTx.com.
About Eikon Therapeutics
Eikon Therapeutics seeks to advance breakthrough therapeutics through the purposeful integration of engineering and science. Our proprietary discovery technologies leverage Nobel Prize-winning super-resolution microscopy, advanced engineering, and high-performance computing to visualize and measure the real-time movement of proteins in living cells, with the goal of bringing important new medicines to people suffering from grievous illness. Eikon operates from its facilities in California, New Jersey, and New York and can be found online via our website or LinkedIn.
Ault Alliance, Inc. , a diversified holding company, ("Ault Alliance" or the "Company"), hereby announces that it has completed the final distribution (the "Final Distribution") of the securities of TurnOnGreen, Inc., formerly Imperalis Holding Corp....
SS&C Technologies Holdings, Inc. (the "Company" or "SS&C") , a global provider of investment, financial and healthcare software and software-enabled services, today announced the pricing of its private placement offering of $750 million in aggregate...
The Armored Vehicle Market is valued at USD 51.6 billion in 2024 and is projected to reach USD 60.7 billion by 2029, at a CAGR of 3.3% from 2024 to 2029 according to a new report by MarketsandMarketstm. The market experiences growth and evolution...
In the news release, Addverb Releases 2023 Sustainability Report Detailing Company's Journey towards Technological Ecology, issued 30-Apr-2024 by Addverb over PR Newswire, we are advised by the company that December 3st, 2023 should read as December...
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...
Arcturis Data Limited ("Arcturis"), a UK leader in Real World Data and Evidence, and Oxford University Hospitals NHS Foundation Trust ("OUH") a global exemplar in clinical, research and digital health excellence, announce today that they are to...
